ZYUS Life Sciences Corporation (TSXV:ZYUS)

Canada flag Canada · Delayed Price · Currency is CAD
0.7500
-0.0400 (-5.06%)
Mar 26, 2025, 4:00 PM EST
-28.57%
Market Cap 58.00M
Revenue (ttm) 452.00K
Net Income (ttm) -36.55M
Shares Out 74.36M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,600
Average Volume 10,815
Open 0.7700
Previous Close 0.7900
Day's Range 0.7500 - 0.7700
52-Week Range 0.7000 - 1.1900
Beta n/a
RSI 48.44
Earnings Date May 8, 2025

About ZYUS Life Sciences

ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada and internationally. The company offers cannabinoid oils, softgel capsules, and topical creams. ZYUS Life Sciences Corporation was founded in 2018 and is based in Saskatoon, Canada. [Read more]

Sector Healthcare
Founded 2018
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol ZYUS
Full Company Profile

Financial Performance

In 2023, ZYUS Life Sciences's revenue was 351,000, an increase of 17.79% compared to the previous year's 298,000. Losses were -42.59 million, 72.7% more than in 2022.

Financial Statements

News

There is no news available yet.